sur Piramal Pharma Solutions
Piramal Pharma's Grangemouth Facility Secures Updated MHRA GMP Certifications
Piramal Pharma Solutions has announced that its Grangemouth, UK facility has received updated MHRA GMP certificates. These certificates cover activities in the Helix building, including its warehouse and labs. Granted after a compliance report and successful inspection, they are valid for three years.
The facility specializes in antibody-drug conjugate development and plays a pivotal role in the ADCelerate™ program. The updated certificates ensure the facility can continue to support drug development with precision and reliability.
The achievement is backed by a strong regulatory history and successful inspections by global health authorities like the USFDA and others. CEO Peter DeYoung highlights this as a commitment to quality, helping partners bring therapies to patients efficiently.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Piramal Pharma Solutions